AtlasClear Holdings faces immediate trading suspension on the NYSE American due to its low share price. The company intends to appeal the delisting proceedings and expects its stock to trade on the OTC market under the symbol ATCH during the process. Despite the exchange action, management reports fiscal 2026 revenue grew 85% to $20.1 million, with $15.4 million in cash, and maintains that clearing operations remain fully compliant.
NYSE American suspended trading in the common stock effective November 10, 2026 and began delisting proceedings under Section 1003(f)(v) based on the low selling price. The stock is expected to move to the OTC market under 'ATCH' during the appeal, which typically costs liquidity, visibility and institutional ownership. The company plans an appeal and a possible reverse split, and cites 85% fiscal 2026 revenue growth to $20.1 million and cash of $15.4 million, but there is no assurance the appeal succeeds or that an active OTC market develops.
- ▼ Trading suspension effective immediately on November 10, 2026 and commencement of delisting proceedings
- ▼ Expected move of the quote to the OTC market under 'ATCH' during the appeal
- ▲ Company states AtlasClearing remains compliant with regulatory net capital requirements and clearing operations continue in the ordinary course
- ▲ Fiscal 2026 revenue increased 85% to $20.1 million and cash more than doubled to $15.4 million without an at-the-market offering